Please provide your email address to receive an email when new articles are posted on . Psoriasis patients who self-administer bimekizumab experienced similar levels of comfort and success with both ...
Industry first single-use auto-injector for both 1ml and 2.25 pre-filled syringes with versatile design for different fill volumes in the same device. Aidaptus has an innovative, patient-centric ...
YORK, Pa., Aug. 30, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced the development of a unique proprietary range of auto-injectors for ...
The patients suffering from chronic disease require a regular dose of medicines, either orally or as injections. The patients prefer the self-injection method as it is easy to use, cost-effective, and ...
Diabetes drugmaker Xeris Pharmaceuticals made a $75 million bet last summer when it went public to back an FDA submission for its shelf-stable glucagon injector pen. Now, more than a year later, Xeris ...
The two companies signed an exclusive collaboration agreement for the Aidaptus auto-injector. Owen Mumford, a medical device manufacturer, announced on May 4, 2022 that it has signed an exclusive ...
TOKYO--(BUSINESS WIRE)--SHL, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, announced today that SHL Marketing Director Steven Kaufman will ...
The Aidaptus ® disposable auto-injector platform, designed by Owen Mumford, will be jointly offered to global biopharma companies to support their drug development programs with engineering and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results